Dr. Siegel on the Treatment of HPV-Associated Head and Neck Cancer

Robert Siegel, MD
Published: Friday, Jul 07, 2017



Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses the treatment for patients with HPV-associated head and neck cancer.

Many cases of head and neck cancer have become associated with HPV, explains Siegel. The implications of high-dose radiation are more consequential since the patients are younger.

Instead of using traditional chemotherapy and radiation regimens, standard doses of chemotherapy drugs have shown HPV-associated cancers shrink quicker, states Siegel.
 
SELECTED
LANGUAGE


Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses the treatment for patients with HPV-associated head and neck cancer.

Many cases of head and neck cancer have become associated with HPV, explains Siegel. The implications of high-dose radiation are more consequential since the patients are younger.

Instead of using traditional chemotherapy and radiation regimens, standard doses of chemotherapy drugs have shown HPV-associated cancers shrink quicker, states Siegel.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How Can We Optimize Outcomes in Head and Neck Cancers with Immunotherapeutic Strategies?Oct 31, 20191.5
Publication Bottom Border
Border Publication
x